PRESS RELEASE published on 05/05/2025 at 15:53, 1 year 4 months ago Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc The Vanguard Group, Inc. discloses a 3.33% stake in Dalata Hotel Group plc as per Form 8.3 with relevant securities details Form 8.3 Vanguard Group Inc. Dalata Hotel Group Plc Stake Disclosure Securities Details
BRIEF published on 05/05/2025 at 15:52, 1 year 4 months ago Vanguard Group Discloses Position in Alphawave IP Group Takeover Code Securities Disclosure Vanguard Group Share Purchase Alphawave IP
PRESS RELEASE published on 05/05/2025 at 15:52, 1 year 4 months ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses an ownership of 4.47% in Mural Oncology plc's ordinary shares as of 02 May 2025 The Vanguard Group, Inc. Irish Takeover Panel Ownership Disclosure Stock Holdings Mural Oncology Plc
BRIEF published on 05/05/2025 at 15:51, 1 year 4 months ago The Vanguard Group Discloses Position in Deliveroo The Vanguard Group Takeover Code Securities Disclosure Deliveroo PLC Shareholding
PRESS RELEASE published on 05/05/2025 at 15:51, 1 year 4 months ago Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc The Vanguard Group, Inc. discloses 5.38% stake in Greencore Group plc as of 02 May 2025. Additional disclosures for Bakkavor Group plc The Vanguard Group Financial Disclosure Stake Disclosure Greencore Group Plc Bakkavor Group Plc
PRESS RELEASE published on 05/05/2025 at 15:50, 1 year 4 months ago Form 8.3 - The Vanguard Group, Inc.: Primary Health Properties plc The Vanguard Group, Inc. discloses a 5.60% interest in Primary Health Properties plc. Additional disclosure on Assura plc. Deals include purchase of 1,035 12.5p ordinary shares at 1.02 GBP per unit The Vanguard Group, Inc. Disclosure Purchase Interests Primary Health Properties Plc
BRIEF published on 05/05/2025 at 15:50, 1 year 4 months ago Vanguard Discloses Significant Position in Dowlais Group plc Form 8.3 Takeover Code Vanguard Group Shareholding Dowlais Group
BRIEF published on 05/05/2025 at 15:50, 1 year 4 months ago Vanguard Group Discloses Stake in Bakkavor Group Form 8.3 Takeover Code Vanguard Group Investment Disclosure Bakkavor Group
BRIEF published on 05/05/2025 at 15:49, 1 year 4 months ago The Vanguard Group Discloses Interest in LondonMetric Property plc Securities Form 8.3 Disclosure Vanguard Group LondonMetric Property
PRESS RELEASE published on 05/05/2025 at 15:49, 1 year 4 months ago Form 8.3 - The Vanguard Group, Inc.: Assura plc The Vanguard Group, Inc. discloses a 5.65% stake in Assura plc as of 02 May 2025 through Form 8.3 filing Form 8.3 Vanguard Group Stake Disclosure Financial Holdings Assura Plc
Published on 09/11/2026 at 21:25, 25 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 4 hours 50 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 15:25, 6 hours 25 minutes ago Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 15:00, 6 hours 50 minutes ago Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 14:30, 7 hours 20 minutes ago AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value
Published on 09/11/2026 at 19:44, 2 hours 6 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 3 hours 35 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 17:30, 4 hours 20 minutes ago NAGRAVISION and Plume Strengthen Connected Home Security for 30 Million Subscribers Worldwide
Published on 09/11/2026 at 07:00, 14 hours 50 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 14 hours 50 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 1 day 2 hours ago Availability of the 2026 Interim Financial Report
